Free press releases distribution network?

Agency / Source: Bruker Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Bruker’s New In-Vivo Xtreme II Optical Preclinical Imaging System is Adding Value in Infectious Disease Research - First installation of new optical imaging system at Institute of Microbiology, University of Lausanne, Switzerland - Bruker.com
Bruker’s New In-Vivo Xtreme II Optical Preclinical Imaging System is Adding Value in Infectious Disease Research

 

PRZOOM - /newswire/ - Lausanne, Switzerland, 2016/06/23 - First installation of new optical imaging system at Institute of Microbiology, University of Lausanne, Switzerland - Bruker.com. NASDAQ: BRKR

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Bruker’s recently introduced preclinical in vivo imaging system In-Vivo Xtreme II™ is accelerating the preclinical research into infectious diseases being undertaken at the Institute of Microbiology at the University of Lausanne, Switzerland. Infectious diseases are the second leading cause of death worldwide. Therefore, gaining a deeper understanding of the dynamics of infection as well as developing new, more effective treatment options remains a major focus for researchers and pharmaceutical companies worldwide.

The new In-Vivo Xtreme II is an optical imaging system that incorporates five imaging modalities as standard on one instrument, providing co-registration of molecular events based on Bioluminescence, Fluorescence, Cherenkov radiation, Direct Radioisotopic Imaging (DRI), and X-ray imaging. Breakthroughs in camera technology, animal support, as well as a fully integrated anesthesia solution characterize the unique performance of the instrument. These features combine to offer flexibility and optimized animal care and end-user safety, whilst achieving highest levels of sensitivity.

Following the first installation of the system in Prof. Dr. Dominique Sanglard’s laboratory in Switzerland, the In-Vivo Xtreme II is being used with a mouse model to understand the dynamics and progression of the yeast Candida albicans infection, and to test potential therapies. Professor Sanglard said: “In our research we face two distinct sets of challenges: Firstly, we want our mice to be housed in optimal conditions when imaging, with the ability to perform anesthesia in a controlled manner. Secondly, we want to be able to see and measure how the infection progresses in mice tissues even with low fungal cell burdens. By utilizing Bruker’s In-Vivo Xtreme II, mice are processed in a controlled and efficient workflow. This is a result of the well-designed SPF (Specific Pathogen Free) chambers and the integration of the anesthesia system, which also protects the end-user from being exposed to harmful agents. The sensitivity of the In-Vivo Xtreme II is extremely high, enabling us to detect very low levels of Candida albicans cells within the kidney and other tissues. This allows us to observe disease progression accurately and to explore where any infection may persist after antifungal therapy.”

“Our goal is to provide researchers with the best preclinical imaging tools,” added Dr. Wulf I. Jung, President of Bruker’s Preclinical Imaging Division. “In vivo small animal optical imaging is an essential tool within Bruker’s preclinical imaging portfolio. The design of the new In-Vivo Xtreme II offers various innovations and enhancements, and we are excited that the system has proven its value and satisfied the needs of Professor Sanglard and his team.”

About Bruker Corporation

For more than 50 years, Bruker (bruker.com) has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Bruker Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Bruker’s New In-Vivo Xtreme II Optical Preclinical Imaging System is Adding Value in Infectious Disease Research

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
In-Vivo Xtreme II™ | Bruker BioSpin Group
Contact: Dr. Thorsten Thiel - Bruker.com 
+49(721)5161 6692 thorsten.thiel[.]bruker.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bruker Corporation securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Bruker Corporation / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT
Sparta Releases Stratas 3.0 and TrackWise Intake
GE Healthcare Signs Agreement with HealthTrust to Supply Radiopharmaceuticals
GE Introduces CardioGraphe - The World’s First Dedicated Cardiovascular CT System
Frost & Sullivan Lauds ClearFlow’s ACT® Technology as a Transformational Force in Post-operative Cardiothoracic Surgery Protocols
ZOLL Receives Health Canada Approval for Two New Models of AEDS
ZOLL Hospital Wearable Defibrillator Receives Premarket Approval from the FDA

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit MagLar, Inc.

Visit  Explorers Vacation Club

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today